Status:
UNKNOWN
Evaluation of Response to Use of Intravesical Ozone Gas in Interstitial Cystitis /Bladder Pain Syndrome
Lead Sponsor:
Anhembi Morumbi University
Conditions:
Interstitial Cystitis, Chronic
Bladder Pain Syndrome
Eligibility:
FEMALE
Phase:
PHASE2
Brief Summary
Interstitial Cystitis / bladder pain syndrome (CI / BPS) is a debilitating pathology with a negative impact on the quality of life of affected individuals. It is characterized as the sensation of pain...
Detailed Description
Interstitial Cystitis / bladder pain syndrome (IC / BPS) is a debilitating pathology with a negative impact on the quality of life of patients. According to the European Society for the Study of IC / ...
Eligibility Criteria
Inclusion
- Interstitial Cystitis
- Bladder pain Syndrome
Exclusion
- Malignant Neoplasm
- Bladder Lithiasis.
- Lower Tract Infections
Key Trial Info
Start Date :
March 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04789135
Start Date
March 20 2020
End Date
March 1 2021
Last Update
March 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Distal Nefrologia e Urologia
Jacareí, São Paulo, Brazil, 12327-300